Ferreira Juan Camilo Arjona Myovant Sciences Ltd. (MYOV) insider trading activity

Ferreira Juan Camilo Arjona is Chief Medical Officer of Myovant Sciences Ltd.. Currently has a direct ownership of 0 shares of MYOV, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2023, when has been sold 246,684 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Ferreira Juan Camilo Arjona Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 10 2023	SELL Sale (or disposition) back to the issuer	-	246,684 Reduced 100.0%	0 Common Shares
Jan 18 2023	SELL Open market or private sale	$29,821 $26.89 p/Share	1,109 Reduced 0.45%	246,684 Common Shares
Jan 04 2023	SELL Open market or private sale	$60,551 $26.9 p/Share	2,251 Reduced 0.9%	247,793 Common Shares
Oct 18 2022	SELL Open market or private sale	$40,421 $25.2 p/Share	1,604 Reduced 0.64%	250,044 Common Shares
Oct 04 2022	SELL Open market or private sale	$66,807 $24.4 p/Share	2,738 Reduced 1.08%	251,648 Common Shares
Jul 18 2022	SELL Open market or private sale	$20,669 $12.87 p/Share	1,606 Reduced 0.63%	254,386 Common Shares
Jul 06 2022	SELL Open market or private sale	$36,917 $13.4 p/Share	2,755 Reduced 1.06%	255,992 Common Shares
May 27 2022	SELL Open market or private sale	$13,917 $10.07 p/Share	1,382 Reduced 0.53%	258,747 Common Shares
Apr 19 2022	SELL Open market or private sale	$48,404 $10.45 p/Share	4,632 Reduced 1.75%	260,129 Common Shares
Apr 15 2022	BUY Grant, award, or other acquisition	-	103,703 Added 28.14%	264,761 Common Shares
Apr 05 2022	SELL Open market or private sale	$26,485 $13.78 p/Share	1,922 Reduced 1.18%	161,058 Common Shares
Mar 01 2022	SELL Open market or private sale	$18,183 $13.35 p/Share	1,362 Reduced 0.83%	162,980 Common Shares
Jan 04 2022	SELL Open market or private sale	$36,949 $16.27 p/Share	2,271 Reduced 1.36%	164,342 Common Shares
Nov 29 2021	SELL Open market or private sale	$38,175 $19.3 p/Share	1,978 Reduced 1.17%	166,613 Common Shares
Nov 04 2021	SELL Open market or private sale	$74,462 $24.02 p/Share	3,100 Reduced 1.81%	168,591 Common Shares
Nov 04 2021	BUY Exercise of conversion of derivative security	$24,118 $7.78 p/Share	3,100 Added 1.77%	171,691 Common Shares
Nov 03 2021	SELL Open market or private sale	$16,800 $24.0 p/Share	700 Reduced 0.41%	168,591 Common Shares
Nov 03 2021	BUY Exercise of conversion of derivative security	$5,446 $7.78 p/Share	700 Added 0.41%	169,291 Common Shares
Oct 05 2021	SELL Open market or private sale	$59,196 $21.62 p/Share	2,738 Reduced 1.6%	168,591 Common Shares
Sep 27 2021	SELL Open market or private sale	$170,240 $24.32 p/Share	7,000 Reduced 3.93%	171,329 Common Shares
Sep 27 2021	BUY Exercise of conversion of derivative security	$54,460 $7.78 p/Share	7,000 Added 3.78%	178,329 Common Shares
Aug 30 2021	SELL Open market or private sale	$505,050 $24.05 p/Share	21,000 Reduced 10.92%	171,329 Common Shares
Aug 30 2021	BUY Exercise of conversion of derivative security	$163,380 $7.78 p/Share	21,000 Added 9.84%	192,329 Common Shares
Aug 27 2021	SELL Open market or private sale	$44,881 $22.69 p/Share	1,978 Reduced 1.14%	171,329 Common Shares
Jul 07 2021	SELL Open market or private sale	$60,400 $21.75 p/Share	2,777 Reduced 1.58%	173,307 Common Shares

Also insider at

OGN

Organon & Co. Healthcare

Head of R&D & CMO

FJC